351 related articles for article (PubMed ID: 15036041)
41. Aiming for successful vaccine-induced HIV-1-specific cytotoxic T lymphocytes.
Yang OO
AIDS; 2008 Jan; 22(3):325-31. PubMed ID: 18195558
[No Abstract] [Full Text] [Related]
42. Dynamic immune responses maintain cytotoxic T lymphocyte epitope mutations in transmitted simian immunodeficiency virus variants.
Barouch DH; Powers J; Truitt DM; Kishko MG; Arthur JC; Peyerl FW; Kuroda MJ; Gorgone DA; Lifton MA; Lord CI; Hirsch VM; Montefiori DC; Carville A; Mansfield KG; Kunstman KJ; Wolinsky SM; Letvin NL
Nat Immunol; 2005 Mar; 6(3):247-52. PubMed ID: 15685174
[TBL] [Abstract][Full Text] [Related]
43. The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes.
Gruters RA; van Baalen CA; Osterhaus AD
Vaccine; 2002 May; 20(15):2011-5. PubMed ID: 11983265
[TBL] [Abstract][Full Text] [Related]
44. Dynamics of immune escape during HIV/SIV infection.
Althaus CL; De Boer RJ
PLoS Comput Biol; 2008 Jul; 4(7):e1000103. PubMed ID: 18636096
[TBL] [Abstract][Full Text] [Related]
45. Vaccines. Monkey puzzles.
Cohen J
Science; 2002 Jun; 296(5577):2325-6. PubMed ID: 12089425
[No Abstract] [Full Text] [Related]
46. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
[TBL] [Abstract][Full Text] [Related]
47. Containing HIV after infection.
Walker BD; Rosenberg ES
Nat Med; 2000 Oct; 6(10):1094-5. PubMed ID: 11017132
[No Abstract] [Full Text] [Related]
48. Cytotoxic T lymphocyte responses to human immunodeficiency virus: control and escape.
Sewell AK; Price DA; Oxenius A; Kelleher AD; Phillips RE
Stem Cells; 2000; 18(4):230-44. PubMed ID: 10924089
[TBL] [Abstract][Full Text] [Related]
49. Why do we not have an HIV vaccine and how can we make one?
Burton DR; Moore JP
Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
[No Abstract] [Full Text] [Related]
50. Studies using a viral challenge and CD8 T cell depletions on the roles of cellular and humoral immunity in the control of an SHIV-89.6P challenge in DNA/MVA-vaccinated macaques.
Amara RR; Ibegbu C; Villinger F; Montefiori DC; Sharma S; Nigam P; Xu Y; McClure HM; Robinson HL
Virology; 2005 Dec; 343(2):246-55. PubMed ID: 16185742
[TBL] [Abstract][Full Text] [Related]
51. The role of CD8+ T-cell response in HIV infection.
Benito JM; López M; Soriano V
AIDS Rev; 2004; 6(2):79-88. PubMed ID: 15332430
[TBL] [Abstract][Full Text] [Related]
52. The HIV hide and seek game: an immunogenomic analysis of the HIV epitope repertoire.
Vider-Shalit T; Almani M; Sarid R; Louzoun Y
AIDS; 2009 Jul; 23(11):1311-8. PubMed ID: 19550286
[TBL] [Abstract][Full Text] [Related]
53. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
54. Efficient expansion of HIV-1-specific T cell responses by homologous immunization with recombinant Semliki Forest virus particles.
Sundbäck M; Douagi I; Dayaraj C; Forsell MN; Nordström EK; McInerney GM; Spångberg K; Tjäder L; Bonin E; Sundström M; Liljeström P; Karlsson Hedestam GB
Virology; 2005 Oct; 341(2):190-202. PubMed ID: 16098555
[TBL] [Abstract][Full Text] [Related]
55. The great escape - AIDS viruses and immune control.
Goulder PJ; Walker BD
Nat Med; 1999 Nov; 5(11):1233-5. PubMed ID: 10545982
[TBL] [Abstract][Full Text] [Related]
56. Mucosally-administered human-simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3.
Kent SJ; Dale CJ; Ranasinghe C; Stratov I; De Rose R; Chea S; Montefiori DC; Thomson S; Ramshaw IA; Coupar BE; Boyle DB; Law M; Wilson KM; Ramsay AJ
Vaccine; 2005 Oct; 23(42):5009-21. PubMed ID: 15985317
[TBL] [Abstract][Full Text] [Related]
57. One step forwards, one step back.
Lifson JD; Martin MA
Nature; 2002 Jan; 415(6869):272-3. PubMed ID: 11796990
[No Abstract] [Full Text] [Related]
58. Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model.
Dittmer U; Hunsmann G
J Gen Virol; 1997 May; 78 ( Pt 5)():979-84. PubMed ID: 9152413
[No Abstract] [Full Text] [Related]
59. Cytotoxic T-cell recognition of HIV proteins and peptides.
Nixon DF; McMichael AJ
AIDS; 1991 Sep; 5(9):1049-59. PubMed ID: 1718319
[No Abstract] [Full Text] [Related]
60. New finding on immune response to HIV Tat may contribute to vaccine, treatment.
James JS
AIDS Treat News; 2000 Sep; (351):4. PubMed ID: 12173551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
